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Abstract.  We have identified an integral  membrane 
glycoprotein in rat liver that mediates adhesion of cul- 
tured hepatocytes on fibronectin substrata.  The protein 
was isolated by affinity chromatography of detergent 
extracts on wheat germ lectin-Agarose followed by 
chromatography of the WGA binding fraction on 
fibronectin-Sepharose.  The glycoprotein (AGpll0), 
eluted at high salt concentrations from the fibronectin 
column, has a molecular mass of 110 kD and a pI of 
4.2.  Binding of immobilized AGpll0 to soluble rat 
plasma fibronectin required Ca  ~÷ ions but was not in- 
hibited by RGD peptides.  Fab' fragments of immuno- 
globulins raised in rabbits against AGpll0 reversed the 
spreading of primary hepatocytes attached onto 
fibronectin-coated substrata,  but had no effect on cells 
spread on type IV collagen or laminin  substrata.  The 
effect of the antiserum on cell spreading was revers- 
ible. AGpll0 was detected by immunofluorescence 
around the periphery of the ventral surface of substra- 
tum attached hepatocytes, and  scattered on the dorsal 
surface. Immunohistochemical  evidence and Western 
blotting of fractionated liver plasma membranes indi- 
cated a bile canalicular  (apical) localization of AGpll0 
in the liver parenchyma.  Expression of AGp110 is tis- 
sue specific: it was found mainly in liver, kidney, pan- 
creas,  and small intestine but was not detected in 
stomach,  skeletal muscle, heart,  and large intestine. 
AGpll0 could be labeled by lactoperoxidase-catalyzed 
surface iodination of intact liver cells and,  after phase 
partitioning  of liver plasma membranes with the deter- 
gent Triton X-114,  it was preferentially distributed in 
the hydrophobic phase.  Treatment  with glycosidases 
indicated extensive sialic acid substitution in at least 
10 O-linked carbohydrate chains and  1-2 N-linked gly- 
cans.  Immunological comparisons  suggest that 
AGpll0,  the integrin  fibronectin receptor and dipep- 
tidyl peptidase IV, an enzyme involved in fibronectin- 
mediated adhesion of hepatocytes on collagen, are dis- 
tinct proteins. 
HESIV~. interactions  between the hepatic parenchyma 
and the surrounding biomatrix are important in main- 
taining the morphological and functional integrity of 
the liver. The extracellular  matrix can modulate the expres- 
sion of liver-specific proteins (5, 25, 46, 55) and, in patholog- 
ical conditions such as cirrhosis and fibrosis, impaired liver 
function may be related to significant alterations  in the distri- 
bution and synthesis of extracellular  matrix components (20, 
47, 48). 
The most abundant  noncollagenous  matrix constituent  in 
adult rat liver is fibronectin,  a major component of bioma- 
trices of connective tissue or epithelial  origin  (1, 25, 49). 
In liver parenchyma,  fibronectin  is  mostly present in  the 
perisinusoidal  space (39), but can also be detected on the 
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lateral  and bile canalicular  cell  surface domains  (18, 25). 
Basement membrane proteins such as type IV collagen and 
laminin  are sparsely distributed on the sinusoidal  surface 
only (25, 39), but a typical basement membrane structure, 
as seen in other epithelia,  has not been observed at the basal 
surface of liver parenchymal  cells. 
Hepatocytes in vitro attach and  spread on extracellular 
matrix proteins including  fibronectin  (7, 30, 31) and a puta- 
tive fibronectin receptor of rat hepatocytes has recently been 
isolated (32). This receptor belongs to the integrin family of 
proteins (29, 49) and binds to the Arg-Gly-Asp  (RGD) se- 
quence in the cell-binding domain of fibronectin,  in common 
with some other integrins (49, 51). In this study we describe 
another protein from rat liver which mediates adhesion  of 
hepatocytes on fibronectin  matrices.  This protein, AGpll0, 
for apical  glycoprotein of molecular mass  110 kD,  is not 
related to the integrin-receptor family but its properties sug- 
gest strongly that it makes an important contribution to the 
adhesive interactions  of liver parenchymal cells with fibro- 
nectin  matrices. 
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Cel/s 
Hepatocytes  were isolated from young adult female Sprague-Dawley  rats 
by liver perfusion with collagenase  (6). Viable cells were further purified 
by Percoll isopycnic centrifugation (37), and cultured in arginine-free DME 
(56) supplemented with 0.5 mM ornithine, 0.1 ~M insulin, 0.025 ~M deXa- 
methasone, 60 ~g/ml penicillin, 100 pg/ml streptomycin,  and 50/~g/ml gen- 
tamycin.  Cell culture substrata were treated with either 25 ~g/ml fibronec- 
tin, 40 ~g/ml type IV collagen, or 40 ~,g/ml laminin in PBS for at least 1 h 
and washed  with PBS;  cells were then seeded  and grown in serum-free 
medium. 
Proteins and Enzymes 
Fibronectin was purified from rat plasma on a gelatin-Sepharose  column 
(17).  Type  IV collagen and laminin were  isolated from the Engelbreth- 
Holm-Swarm  (EHS)  sarcoma implanted in lathyritic mice as  described 
(36). Collagenase (type IV; Sigma Chemical Co., St. Louis, MO), ovalbu- 
rain, bovine albumin, lactoperoxidase,  and glucose oxidase were purchased 
from Sigma Chemical Co. Wheat germ agglutinin was obtained from Phar- 
macia Fine Chemicals (Piscataway,  NJ).  GRGDS peptide was  obtained 
from Calbiochem-Behring Corp, (La Jolla, CA). 
Glycosidase F (N-glycanase),  endnglycosidase  F (Endo F), and endo-c~- 
N-acetylgalactosaminidase  (O-glycanase) were purchased from Boehringer 
(Mannheim, FRG)  and  O-glycanase  was  also  obtained from Genzyme 
Corp.  (Boston, MA): results using O-glycanase  from these two  sources 
were indistinguishable.  Vibrio cholerae neuraminidase was from Calbio- 
chem-Behring Corp. 
Radioactive Labeling 
For metabolic labeling, cell cultures in petri dishes were incubated in low- 
methionine medium for 1 h and then grown for 1-16 h in low-methionine 
medium containing 100 ~Ci/ml of [35S]methionine. In some experiments 
cell cultures were treated with 1 #M tunicamycin for 3 h followed by addi- 
tion of [35S]methionine and labeling over a further 16 h. 
Surface  labeling  was  carried  out  according  to  the  lactoperoxidase- 
catalyzed iodination procedure using carrier-free 12sI (0.5 mCi/ml) as de- 
scribed (12, 24). 
Electrophoretic Techniques 
SDS-PAGE and tv~-dimensional electrophoresis were carried out as de- 
scribed (38, 44). Western blotting of proteins on nitrocellulose and detec- 
tion using antibody probes was performed according to established proce- 
dures (10, 15) as described (54).  For preparative electrophoresis,  proteins 
were run on 7-12% SDS polyacrylamide  gels under reducing conditions, 
stained for 30 min with 0.1% Coomassie blue and destained with 30% meth- 
anol in 10% acetic acid. The bands of interest were cut out and destained 
further at 37°C with 50% methanol in 0.1 M Tris, pH 8.8. The destained 
bands were  washed exhaustively  with distilled H~O and before  elution, 
were incubated for 30 rain in a  minimal volume of SDS-PAGE sample 
buffer. The protein was eluted from the gel in a  10-ml disposable pipette 
that was cut to appropriate size and fitted with a dialysis membrane bag at 
the tip. 
A~inity Chromatography 
Rat plasma fibronectin and WGA were coupled to CNBr-activated  Sepha- 
rose (5 mg/ml gel) as recommended (Pharmacia Fine Chemicals). Affinity 
chromatography on both WGA and fibronectin columns was performed at 
4°C.  Hepatocytes  or purified canalicular membranes were extracted with 
25 mM octyl glucoside in Hepes-saline (10 mM Hepes,  pH 7.1, 150 mM 
NaCI)  containing 1 mM PMSF,  1 mM NEM,  2 mM CaC12, and 2 mM 
MgC12. The extract was centrifuged for 30 rain at 25,000  rpm in a rotor 
(model 42.1; Beckman Instruments, FuUerton,  CA) and the clear superna- 
tant was applied to a WGA-Sepharose column (5  x  2 cm) equilibrated with 
the same extraction buffer.  Unbound material was removed by extensive 
washing with the same buffer and bound proteins were eluted with 1 M 
N-acetylglucosamine  in buffer.  Fractions (2 ml) were collected and peak 
fractions were dialysed versus Hepes-saline pH 7.1, 1 mM PMSF,  1 mM 
N-ethylmaleimide,  1 mM octyl glucoside.  This fraction was made up to 25 
mM octyl glucoside,  2 mM CaC12, 2 mM MgCI2 and applied to a flbro- 
nectin-Sepharose column (5  x  2 cm) equilibrated in the same buffer as 
above.  Elution of bound material was effected by  1 M  NaCI in 10 mM 
Hepes,  pH 7.1 containing 25 mM octyl glucoside or by 20 mM EDTA in 
the same buffer.  2-ml fractions were  collected and peak fractions were 
pooled for further analysis. 
lon Exchange Chromatography 
AGp110, isolated from bile canalicular membranes by WGA affinity chro- 
matography followed by fibronectin affinity chromatography,  was purified 
further by ion exchange chromatography on a Mono Q column using the 
Pharmacia FPLC syst¢m. AGp110  eluted from a fibronectin column with i M 
NaCI was dialysed versus distilled H20 containing 1 mM octyl glucoside 
and then versus 20 mM piperazine. HCI,  pH 5, containing 25 mM octyl 
glucoside.  The glycoprotein  was then loaded onto the column and eluted 
with a linear NaC1 concentration gradient (0-1 M NaC1) in 20 mM pipera- 
zine, HCI pH 5, 25 mM octyl glucoside.  AGpll0 eluted at ",~0.3 M NaCI. 
Antibodies and Isolation of lgG Fragments 
Antisera against rat plasma fibronectin and AGpll0 were raised in rabbits 
by intradermal injection at several  sites in Freund's adjuvant  followed by 
weekly  booster injections  5  wk  after the primary injection.  To  obtain 
sufficient amounts of AGpll0 to raise antibodies, we extracted  crude liver 
plasma membranes with 0.3%  deoxycholate  and applied the extract to a 
WGA Sepharose column equilibrated in the same buffer. The binding frac- 
tion that eluted with 1 M N-acetyl-D-glucosarnine  was dialysed versus dis- 
tilled H20 and lyophilized.  The lyophilized  sample was dissolved  in elec- 
trophoresis sample buffer and run on preparatory SDS gels. The bands with 
Mr 110 kO were excised and electroeluted.  This electroeluted antigen was 
used for injecting rabbits.  Subsequent booster injections were with AGp110 
isolated from bile canalicular membranes by WGA-agarose and flbronectin- 
Sepharose affinity chromatography.  Rabbit antisera against the B-subunit of 
fibronectin receptor integrin and dipeptidyl peptidase  IV (DPPIV) I were 
kind gifts from Dr.  S. Johansson (Biomedical  Center, Uppsala, Sweden) 
and Dr. D. Doyle (State University of New York at Buffalo, NY), respec- 
tively. Anti-rabbit IgG/rhodamine was purchased from Cappel Laborato- 
ries (Cochranville, PA), anti-rabbit IgG/horseradish peroxidase  and anti- 
rabbit IgG/alkaline  phosphatase from Sigma Chemical Co. 
Immunnglobulin G was isolated from AGp110 immune sera on a protein 
A-Agarose (Pharmacia Fine Chemicals) column equilibrated in PBS. Bound 
IgG was eluted with 0.6% glacial acetic acid in 0.15 M NaC1 (19). The pH 
of the eluate was neutralized with solid Tris.  (F(ab')2 fragments were ob- 
tained as described (19): briefly, IgG solutions were dialysed versus 0.2 M 
acetate buffer, pH 4.5, and digested with 2 % pepsin (weight enzyme/weight 
IgG) overnight at 37°C, The digested IgG was dialysed versus PBS, passed 
through the protein A-Sepharose column and the F(ab')2 fragments  were 
recovered in the flowthrough  fraction.  Fab' fragments  were obtained after 
reduction and alkylation of F(ab')2 dimers (13): reduction was effected with 
0.11 vol of 0.1 M DTT in 0.2 M Tris HCl, pH 8.0 containing 10 mM EDTA 
for 1 h at room temperature; 0.11 vol of  0.22 M iodoacetamide in Tris/EDTA 
were then added and alkylation was allowed to proceed for 30 min at 4°C. 
FalY fragments were used in adhesion experiments after extensive dialysis 
against 10 mM Hepes,  pH 7.2 
ELISA 
The binding of AGpll0 to fibronectin was investigaW.d by an ELISA.  In 
these experiments,  we used AGp110 isolated from purified bile canalicular 
membranes  by  WGA-Agarose  affinity  chromatography,  Fn-Sepharose 
affinity chromatography,  and Mono Q FPLC ion exchange. Fibronectin was 
isolated from rat plasma.  The purity of both proteins was confirmed by 
PAGE followed by silver staining. 
Purified AGp110 was suspended in "sensitizing" buffer (4.5 ml of 0.2 M 
Na2CO3 and 8 ml of 0.2 M Na2HCO3, made up to 50 ml with distilled wa- 
ter) containing 0.05%  Tween 20 and dispensed in microtiter plate wells: 
,'~0.1 #g/100/xl AGplI0 was used per well. The plates were then incubated 
overnight at 4°C. The wells were washed with PBS and unoccupied binding 
sites on polystyrene were blocked by incubation with 10% BSA in PBS pH 
7.3 for 1 h at 37°C.  A stock solution of fibronectin (630/~g/ml) was used 
at dilutions ranging from 1:5 to 1:5,000 and dispensed in 100-/~1 amounts 
in individual wells. The incubation buffer used was PBS pH 7.3 containing 
1%  BSA,  4  mM CaCI2,  and 0.05%  Tween  20.  This buffer  (incubation 
1. Abbreviations used in this paper: DPPIV, dipeptidyl peptidase IV; NEM, 
N-ethylmaleimide. 
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incubated with fibronectin for 1 h at 37°C and then extensively washed. 
anti-fibronectin serum was added at a dilution of 1:200 and left for 1 h at 
37°C. After extensive washing, the plates were incubated for 1 h at 37°C 
with anti-rabbit IgG conjugated to alkaline phosphatase (1:400).  The wells 
were again exhaustively washed and alkaline phosphatase substrate (p-ni- 
trophenyl phosphate from Sigma in sensitizing buffer containing 0.1% of 
0.5 M  MgC12) was added (100/~l/well).  Wells were developed with this 
chromogen for 2 h at 37*C.  Absorbance at 400 nm was read in a Titertek 
Multiskan (Flow Laboratories, Maclean, VA). 
Controls  for these experiments consisted of wells with no absorbed 
AGpI10 but otherwise processed as described above. These gave very low 
absorbance readings. The amount of AGpll0 absorbed onto polystyrene 
was found to be 'x,90% of added protein: solutions of AGpll0 were allowed 
to adsorb onto polystyrene wells as described and then transferred to new 
wells on the same plate and incubated further under the same conditions. 
The plates were developed using anti-AGp110 and anti-rabbit IgG-alkaline 
phosphatase followed by chromogenic substrate as described above. The ra- 
tio of absorbances (primary over secondary incubation) was ~10:1 with no 
significant variation among triplicate experiments. A third incubation did 
not give detectable absorbance. The amount of fibronectin linked to AGp110 
was determined by referring to a standard curve: we found that, as in the 
case of AGpll0,  ,~80-90%  of fibronectin in solution adsorbed onto the 
polystyrene wells after overnight incubation. Fibronectin at different dilu- 
tions was incubated in mierotiter plate wells and the wells were processed 
with anti-Fn serum, alkaline phospbatase-linked secondary antibody and 
chromogen. Estimated amounts of bound fibronectin were plotted against 
OD readings. A fibronectin standard curve was plotted with every experi- 
ment and incubation with chromogenic substrate was for identical times as 
for plates with preadsorbed AGpll0. In experiments designed to study the 
affinity of AGpll0 for the RGD sequence on fibronectin, wells with ab- 
sorbed AGp110 were incubated with solutions of  GRGDS for 30 min at 370C 
and the peptide was also included in the incubation buffer during the reac- 
tion with fibronectin. In experiments describing the effect of calcium, the 
ion was omitted from all incubation buffers. 
Adhesion Experiments 
Nunclon four-well multidishes (Nunc,  Roskilde,  Denmark) were coated 
with fibronectin (30 t~g/ml),  type IV collagen (40/zg/mi), or laminin (40 
#g/ml) for 1 h at 37°C. Free-binding sites on the surface of these substrata 
were blocked with albumin (5 mg/ml, heat treated to 56"C) for 1 h at 37°C. 
Hepatocytes, freshly isolated by collagenase liver perfusion, were treated 
with 20/zM cycloheximide in oxygenated serum-free medium for 1 h at 
37°C and seeded in the presence of cycloheximide  and 0.1% heat-treated al- 
bumin onto the prepared substrata. Cell attachment and spreading was al- 
lowed to proceed for 3 h at 37°C. To test the effects of the AGp110 antiserum 
on cell spreading, solutions of FalY fragments (100-1,000 ttg/mi) in 10 mM 
Hepes, pH 7.2, containing 1 mg/ml albumin were mixed with equal volumes 
of twice-concentrated DME medium and added to the cultures. The effect 
of these antibodies was monitored with an inverted Zeiss microscope after 
further incubation at 370C. 
Immunoprecipitation 
Hepatocyte primary cultures that were either metabolically labeled or sur- 
face-iodinated were extracted with detergent and immunoprecipitated ac- 
cording to an established protocol (55). The procedure was modified to in- 
clude a preclearing step as follows: hepatocytes were extracted by boiling 
in 0.2 M "Iris buffer, pH 8.0, containing 0.2 % SDS, 1 mM PMSF, and 1 mM 
NEM. Preimmune rabbit serum at a final dilution of 1:20 was then added 
to 2 vol of cell extract, 1 vol of 2 % NP-40, 2 % sodium deoxycholate, and 
I vol of 1% BSA. The mixture was incubated with agitation for 1 h at 37°C 
and then a suspension of protein A-Sepharose 6MB was added at a final 
dilution of 1:5. The cell extract was incubated for 1 h at 37°C, the beads 
were spun offand the supernatant was retreated with fresh protein A-Sepha- 
rose, These pre-clearing steps did not remove any AGpll0 from the deter- 
gent extracts. The supernatants, after the two preclearing steps, were used 
for immunoprecipitation with the antisera of interest (1:20 dilution), fol- 
lowed by incubation with protein A-Sepharose at 1:5 dilution. The beads 
were washed four times in 0.1 M Tris, pH 8, containing 0.1% SDS, 0.5% 
NP-40, and 0.5% DO(= and suspended in sample buffer for electrophoresis. 
Radioiodinated hepatocytes used for immunoprecipitations under non- 
dissociating conditions were extracted overnight in cold Hepes-saline (10 
mM Hepes,  150 mM NaCI) pH Z3  containing 10 mM CHAPS, 2  mM 
PMSF/NEM, and 1 mM CaCi2/MgC12.  The soluble extract was separated 
from the residue by centrifugation, precleared twice with nonimmune rabbit 
serum and protein A-Sepharose and once with protein A-Sepharose alone 
and used for immunoprecipitations. Incubations and dilutions of antisera 
were as before but the nondissociating buffer, Hepes-saline pH 7.3 contain- 
ing 10 mM CHAPS, was used throughout in incubations and washes. 
Immunoprecipitated proteins in SDS gels, labeled with either [35S]me- 
thionine or 125I were detected by fluorography or indirect autoradiography 
respectively. FOr fluorography, gels were impregnated with  IM  sodium 
salicylate before drying. For indirect autoradiography, high-speed X inten- 
sifying screens (X-ray Accessories Ltd., Watford, UK) were used on dried 
gels. Kodak XAR-5 x-ray film was used throughout. 
Immunofluorescence 
Frozen sections of rat liver were dried, fixed for 3 rain in a chloroform:ace- 
tone (1:1) mixture, drained and stored at -20°C. Before immunofluorescent 
staining sections were washed in PBS for at least 1 h. Both primary and 
secondary, fluorophore-conjugated, antibodies were diluted  1:50  in PBS 
containing 1% albumin. Incubations were for 1 h at 37°C. 
Live bepatocytes were stained for AGpll0 by incubating for 100 min 
with anti-AGpll0 IgG (1:50),  rinsing and then incubating for 10 rain with 
rhodamine-conjugated anti-rabbit IgG (1:50). 
Glycosidase Digestion of Glycoproteins 
Glycosidase treatments were performed on preparations obtained by immu- 
noprecipitafion. Protein A-Sepharose beads carrying immunoprecipitate 
(•1,000  cpm 125I) were incubated with various glycosidases overnight at 
37°C. For neuraminidase treatment, the beads were suspended in 100 td 
of 25  mM sodium acetate buffer, pH 6.1, containing 20 mU of Vibrio 
cholerae  neuraminidase. The beads were then washed with 0.5 M Tris-HCl, 
pH 6.8. For endoglycosidase F treatment, the protein A-Sepharose beads 
were incubated overnight at 37°C in 100 t~l of 0.25 M sodium acetate, pH 
6.5,  containing 10 mM/~-mereaptoethanol and 0.2 units of Endo E  For 
O-glyeanase treatment, protein A-Sepharose beads were incubated first 
with neuraminidase as above. The beads were then washed with 10 mM so- 
dium acetate, 20  mM sodium cacodylate, pH 6.1, containing  1%  octyl 
glucoside and finally incubated overnight in 100 #1 of the same buffer con- 
taining 5 mU of O-glycanase. For N-glycanase treatment, protein A-Seph- 
arose beads with bound AGp110 were washed with PBS, pH 7.2, containing 
10 mM EDTA, 10 mM/3-mereaptoethanol, and 1% octyl glucoside and in- 
cubated overnight in 100/zl of the same buffer containing 2 U of N-glycan- 
ase. All the reactions with glycosidases were stopped by boiling in PAGE 
sample buffer. 
Controls for the glycanase treatments mentioned above included diges- 
tion of fetuin (5/zg) with the various enzymes and incubation of AGplI0 
with the relevant buffers in the absence of enzymes. The result confirmed 
enzymatic cleavage of glycans from fetuin and no degradation of AGpll0 
during incubations in the absence of glycanases. 
Plasma Membrane Isolation and Fractionation 
Crude  membranes  were  isolated  from  liver  homogenate  in  1  mM 
NaHCO3,  pH 8.  The homogenate was centrifuged at 5,000 rpm and the 
pellet was recovered. Specific domains of parenchymal plasma membranes, 
i.e,, sinusoidal, lateral, and canaiicular were isolated from liver homog- 
enates on sucrose gradients (59). Purified membrane fractions were parti- 
tioned in Triton X-114 as described (3,  8).  The detergent Triton X-114 
achieves an aqueous and hydrophobic phase partition in solution and inte- 
gral membrane proteins having abundant nonpolar residues distribute in the 
hydrophobic (detergent) phase. About 200 #g of membrane proteins were 
used in this fractionation. Aliquots of the aqueous and detergent phases 
were electrophoresed, transferred onto  nitrocellulose and overlaid with 
anti-AGp110 serum. In other experiments, plasma membranes were treated 
with 2  M  NaCI  to remove peripheral proteins.  Membrane pellets were 
homogenized in 50 mM Tris, pH 7.5 containing 2  M  NaCI and agitated 
for 1 h at 4°C. The suspension was centrifuged in a rotor (42.1;  Beckman 
Instruments) for 2 h at 40,000 rpm. This salt extraction was repeated once 
more, the final membrane pellet was extracted with 1% deoxycholate and 
the residue was centrifuged down and discarded. The content of AGp110 in 
the detergent and pooled high salt extracts was compared by running SDS 
gels, blotting, and overlaying with anti-AGpll0 antiserum. 
Tissue Extractions 
Tissues were obtained by dissection of an adult female rat. The tissues were 
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and silver-stained 5-12% gradient gels (land g). (a) Octyl gluco- 
side extract of radioiodinated hepatocytes.  (b) WGA-bound cell 
surface glycoproteins of iodinated  hepatocytes.  (c)  Fraction  of 
WGA-bound cell  surface iodinated glycoproteins eluted  from a 
fibronectin-Sepharose  affinity column with I M NaC1. (d) Cell sur- 
face iodinated glycoproteins eluted from a fibronectin-Sepharose 
column by 20 mM EDTA. (e) WGA-bound iodinated cell surface 
glycoproteins that did not bind to fibronectin Sepharose. (f) Fibro- 
nectin-binding fraction of WGA-bound  glycoproteins from canalic- 
ular plasma membranes extracted with octyl glucoside. This frac- 
tion was eluted from a fibronectin-Sepharose column with  1 M 
NaCI. (g) AGpll0 purified from canalicular membranes by WGA 
and Fn affinity chromatography, followed by Mono Q FPLC. 
thoroughly  rinsed with PBS and then extracted  in Tris-saline  pH 7.4 con- 
taining 200 rnM octyl  glucoside, 2 mM EDTA, 2 mM PMSE and 2 mM 
NEM. The tissues were chopped in small pieces  and left in the detergent- 
containing  buffer  for 4 h on ice before  spinning  out the remnants  at 10,000 g 
for 20 rain  at 2°C. The amount  of  protein  in the supernatants  was estimated 
by the Pierce  BCA assay (Pierce  Chemical Co., Rockford,  IL). For elec- 
trophoresis, equal amounts (100 #g) of protein were applied to 7.5 % gels, 
transferred to nitrocellulose  and probed  with specific  antibodies. 
protein to fibronectin required calcium and/or magnesium 
ions. Neither the high salt nor EDTA eluates contained pro- 
teins migrating in SDS gels with molecular weights similar 
to those observed (32) for the tx and/3 subunits of the liver 
integrin fibronectin receptor, 145 and 130 kD, respectively. 
We conclude that integrin does not bind to whole rat fibro- 
nectin under the experimental conditions used in our affinity 
chromatography and  is  presumably  eluted with  the flow- 
through fraction (Fig. 1 e). This fraction also appears to con- 
tain a major band of •110  kD proteins. Rechromatography 
of  the flowthrough fraction on the fibronectin column yielded 
additional amounts of the ll0-kD component in the high salt 
and EDTA eluates and essentially complete depletion was 
reached only after three rounds of chromatography (results 
not shown). In all cases the flowthrough fraction contained 
other proteins of molecular mass ~110-kD, whose identity 
is discussed later. 
Larger amounts of  an AGp110 fraction were prepared from 
liver membranes and used to raise antibodies in rabbits. The 
antiserum  reacted  strongly with  AGpll0  purified  from a 
fibronectin-Sepharose affinity column (Fig. 2 a). In Western 
blots of two-dimensional gels of WGA-bound glycoproteins 
of liver membranes,  reaction with anti-AGpll0 revealed a 
single major spot at an indicated isoelectric point value of 
4.2 (Fig.  2 b). 
In  addition to chromatography, evidence for affinity of 
AGp110 for fibronectin was provided by ELISA experiments 
in which AGpll0 was immobilized on microtiter wells and 
its association with rat plasma fibronectin was assessed using 
fibronectin-specific antibody probes. For these experiments 
AGp110 was purified to homogeneity from bile canalicular 
membrane preparations using WGA-Agarose and fibronec- 
tin-Sepharose affinity chromatography (Fig. l f) followed by 
Mono Q FPLC (Fig. 1 g). Fibronectin bound to immobilized 
AGp110 in a  saturable manner (Fig,  3 a). Binding was not 
RGD-directed since association was not significantly reduced 
by addition of  the pentapeptide GRGDS (Fig. 3 b). However, 
Results 
Identification of  AGpllO 
Rat hepatocytes see~ied onto substrata derivatized with fibro- 
nectin were surface-labeled with ~2sI and extracted with oc- 
tyl glucoside (see Materials and Methods).  The detergent 
extract (Fig. 1 a) was chromatographed on a wheat germ ag- 
glutinin-Agarose column and glycoproteins  bound to the lec- 
tin were eluted with 1 M N-acetyl-D-glucosamine. This frac- 
tion (Fig. 1 b) was applied to a fibronectin-Sepharose affinity 
column and proteins  eluted with  1 M  NaC1  and  20 mM 
EDTA were analyzed by SDS electrophoresis (Figs. 1, c and 
d, respectively). The results indicated that a glycoprotein of 
molecular mass  110  kD  was  retained  by  the  fibronectin 
column.  Binding  of AGpll0 to  fibronectin seemed to be 
specific under the experimental conditions described above 
since the protein was  not retained  in  affinity columns of 
Sepharose derivatized with type IV collagen, laminin, albu- 
min, or protein A or in columns of underivatized Sepharose. 
Elution of the fibronectin-Sepharose column by EDTA, i.e., 
by divalent ion chelation, indicated that binding of the glyco- 
Figure 2. Characterization of anti-AGp110 serum. (a) Western blot 
of  purified AGp110  stained with anti-AGp  serum followed  by horse- 
radish peroxidase-goat anti-rabbit  IgG. (b) Western blot of two- 
dimensional gel  of liver membrane  proteins  probed  with  anti- 
AGpll0 serum. The spot detected at the molecular mass position 
of 110 kD has a pI of 4.2. 
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Figure 3. Characteristics of AGp110 binding to rat plasma fibronec- 
tin. Points on graphs are mean values from triplicate experiments. 
Deviations from  mean  values  are  'M0%.  Constant  amounts  of 
Figure  4.  Relative quantities  of 
AGp110 in fractionated liver  plas- 
ma membranes.  100 #g of mem- 
brane proteins from each mem- 
brane fraction were separated by 
SDS-PAGE,  blotted  onto  nitro- 
cellulose and  treated  with  anti- 
AGpll0  serum.  (a)  Lateral 
membranes; (b) canalicular mem- 
branes; (c) sinusoidal membranes. 
omission of calcium ions from incubation buffers resulted in 
decreased  binding (Fig.  3 c). 
Localization  in Rat Liver Membranes 
Western blotting of purified plasma membranes  from the si- 
nusoidal, lateral and canalicular cell surface domains of the 
liver parenchyma using anti-AGp110 serum indicated that the 
protein  is  located  predominantly  in  the  bile  canalicular 
plasma  membrane domain  (Fig.  4).  Secretion  of AGpll0 
into the bile canaliculus  does not seem to occur since the 
protein could not be detected in bile fluid by Western blotting 
(result  not shown).  Immunofluorescent staining  of frozen 
liver sections  (Fig.  5  a)  affirmed antigen  residency  exclu- 
sively on the bile canalicular  surface and provided  no evi- 
dence for sinusoidal or lateral membrane localization,  thus 
suggesting  that the low level of expression of AGp110 found 
in Western blots of sinusoidal and lateral membranes  (Fig. 
AGp110 ('~0.1 #g) were immobilized on microtiter plate wells and 
incubated with fibronectin solutions of various concentrations. The 
wells were then incubated with rabbit anti-rat plasma fibronectin 
followed by anti-rabbit IgG conjugated with alkaline phosphatase. 
The OD4oo values obtained after reaction with chromogen were 
compared with those of a standard curve for fibronectin, and the 
amount of fibronectin attached to immobilized AGp110 was quanti- 
tated. (a) Semi-log plot of added versus bound fibronectin. Satura- 
ble binding was observed. (b) Plot of fibronectin bound to AGp110 
versus amount of soluble GRGDS peptide in incubation buffer. The 
result indicates minimal inhibition of binding. (c) Effect of calcium 
on fibronectin binding to AGpll0. A  significant reduction in the 
amount of fibronectin bound to AGpl  I0 was observed in buffers 
lacking calcium. 
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tured hepatocytes by immunofluorescence. Immunofluorescent im- 
age of  AGp110  localization using anti-AGp110  serum on frozen liver 
sections. The antigen is seen along the bile eanaliculi. Bar, 20/zm. 
(b) Localization of AGp110 on live hepatocytes by immunofluores- 
cence.  Hepatocytes were  cultured on fibronectin in  serum-free 
medium at 37°C for 3 h before exposure to anti-AGp110 antibodies. 
The photograph depicts a double exposure at different focal planes. 
Focusing was on the substrate plane and close to the top cell sur- 
face. AGp110  is visualized along the periphery of  the ventral surface 
close to the substratum and scattered over the dorsal cell surface. 
Bar, 10 #m. 
ton  X-114  extraction and  phase  separation  of canalicular 
membranes (Fig.  6, a  and b) and could not be dissociated 
from the plasma membrane after treatment with 2 M NaC1 
(Fig. 6, c and d). On the basis of these experiments we con- 
clude that AGp110 is an integral membrane protein of hepa- 
tocytes with an extracellular domain. 
Role of  AGpllO in the Adhesion of Rat 
Hepatocytes on Fibronectin 
Since AGpll0 was shown to be exposed on the hepatocyte 
cell surface and to interact with fibronectin, we investigated 
its possible role in hepatocyte adhesion to fibronectin by 
studying the effect  of  the AGp110 specific antiserum on hepa- 
tocytes cultured on fibronectin substrata. 
Hepatocytes were allowed to spread on fibronectin sub- 
strata in serum-free medium in the presence of the protein 
synthesis inhibitor cycloheximide. The use of cycloheximide 
was deemed necessary in view of the fact that hepatocytes 
in vitro synthesize copious amounts of fibronectin and lesser 
amounts of other adhesive matrix proteins (such as type IV 
collagen and laminin) whose deposition on the substratum 
would have invalidated comparison of results from ceils on 
different substrata (54-56).  3 h  after inoculation monova- 
lent Fab' fragments of anti-AGpll0 IgG were added in the 
culture medium and caused rapid rounding of the cells (Fig. 
7 b) compared with control cultures (Fig. 7 a). Control ex- 
periments using  Fab' fragments of nonimmune rabbit IgG 
were  totally  negative.  Ruffling  activity  at  the  peripheral 
lameUa of spread hepatocytes could be noticed under the mi- 
croscope just 10 min after adding the AGp110 specific anti- 
bodies. The adverse effect of anti-AGpll0 Fab' fragments on 
hepatocyte spreading was independent of cell density and in- 
tercellular contacts: experiments in which hepatocytes were 
inoculated on fibronectin-coated substrata at different cell 
densities demonstrated that single cells or colonies of hepa- 
tocytes were equally prone to reversal of spreading after anti- 
body  treatment  (results  not  shown).  Fab'  concentrations 
ranging from 500 to 50 #g/ml were tested and found to be 
effective in rounding up hepatocytes spread on fibronectin 
substrata. The ceils remained viable throughout the antibody 
4) is due to cross-contamination with membranes from the 
canalicular domain. 
In vitro AGp110 was found on the substrate contact area 
along the periphery of the hepatocyte ventral surface, but 
was also scattered over the entire dorsal surface (Fig. 5 b). 
The  protein  was  neither  incorporated  into  the  fibronec- 
tin/fibrin matrix that hepatocytes synthesize in vitro (54) nor 
absorbed onto the fibronectin-coated culture substratum as 
shown  by  immunofluorescence  experiments  (results  not 
shown). 
AGpll0 is exposed on the cell surface, since it was labeled 
by  lactoperoxidase-catalyzed iodination  of intact  hepato- 
cytes.  To  investigate  the  interaction  of AGpll0  with  the 
membrane lipid bilayer, purified bile canalicular membranes 
were extracted with Triton X-114 or with buffers of high ionic 
strength, and the presence of the protein in each extract was 
probed with the antiserum in Western blots.  AGpll0 was 
found mainly in the detergent (hydrophobic) phase after Tri- 
Figure 6. Membrane associa- 
tion of AGpll0.  (a) Western 
blot of liver membrane  proteins 
distributed in the aqueous 
phase after Triton X-114 frac- 
tionation. Blot treated with 
anti-AGp110. (b) Western blot 
of liver membrane  proteins dis- 
tributed in the detergent phase 
after Triton  X-114 fractiona- 
tion. Treatment with AGplI0 
antiserum reveals AGpI10 in 
this phase. (c) Western blot of 
liver membrane residue after 
2 M NaCI extraction. (d) West- 
ern blot of high-salt extract of 
liver membranes. 
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tions up to 500/zg/ml (results not shown). 
We also  examined the effect of the antiserum on ceils 
spread on type IV collagen or laminin substrata. As shown 
in Fig. 8, the anti-AGpllO Fab' fragments caused no notice- 
able reversal of cell spreading on either type IV collagen 
(Fig. 8 b) or laminin (Fig. 8 d) when compared with control 
cultures (Fig. 8, a  and c, respectively). 
Figure 7. Effect of AGp110 antibody on hepatocytes spreading on 
fibronectin sul~strata. Bar, 50/zm.  (a) Hepatocytes seeded onto a 
fibronectin-coated  substratum in the presence of  cycloheximide  and 
allowed to spread for 3 h. (b) Hepatocytes were allowed to spread 
for 3 h on a fibronectin substratum as in a and then incubated for 
1 h in medium containing 500/zg/ml monovalent  Fab' fragments of 
AGpll0 antibodies. (c) Hepatocyte cultures were treated with Fab' 
fragments as in b, the culture medium was replaced with medium 
without Fal~ and the cells were incubated for a further hour. 
treatment as shown by the fact that cellular spreading on 
fibronectin substrata was reestablished after removal of the 
Fab fragments from the culture medium (Fig. 7 c). The FalY 
fragments did not induce detachment of the ceils, even after 
prolonged exposure and initial attachment of hepatocytes 
Glycosylation of  AGpllO 
Since AGpll0 binds to WGA, it is clearly a glycoprotein. 
Further information on the extent and type of glycosylation 
was sought by making use of specific glycosidases. Hepato- 
cytes spread on fibronectin were radioiodinated, extracted in 
0.2%  SDS  (see Materials and Methods) and AGp110 was 
specifically immunoprecipitated.  The  immunoprecipitates 
were then digested with various  glycosidases. Endo E  which 
cleaves high-mannose, hybrid, and some complex oligosac- 
charities attached through an N-linkage to asparagine, pro- 
duced  a  small  but  reproducible  molecular mass  shift of 
'~2-3 kD (Fig. 9 b; compare with control, a). On the other 
hand, removal of sialic acid with neuraminidase reduced the 
molecular mass to 94 kD (Fig. 9 c), a reduction of 16 kD. 
Assuming complete removal of N-linked chains by Endo E 
these results indicate an abundance of terminal sialic acid 
residues on carbohydrate chains O-linked to serine or threo- 
nine. However,  since the protein may contain N-linked sac- 
charities that are not cleaved by Endo F, we repeated the ex- 
periment using N-glycanase, which removes a broader range 
of complex asparagine-linked carbohydrate structures than 
endo F and O-glycanase, which releases O-glycans from ser- 
ine or threonine. Since substitution with sialic acid at the 
core Gal(~l-*3)GalNAc of  O-glycans prevents release of this 
disaccharide, we first treated the immunoprecipitated AGp110 
with neuraminidase: the asialoprotein migrated to 94 kD 
(Fig. 9 e) as noted in the previous experiment (Fig. 9 c). Sub- 
sequent hydrolysis with O-glycanase resulted in a molecular 
weight shift of ~5 kD (Fig. 9 f), confirming the presence 
of  O-glycans. Digestion with N-glycanase increased the dec- 
trophoretic mobility of the protein (Fig. 9 g) by a magnitude 
similar to that obtained after Endo F hydrolysis (Fig. 9 b). 
These results indicate the presence of "ol-2 N-glycans and 
an abundance (at least 10 chains)) of O-glycans. The number 
of carbohydrate  chains  cannot be  determined  accurately 
since removal of polysaccharides may alter the association 
of SDS with the protein, thus disproportionately affecting 
its  mobility in  SDS  gels.  Further proof on the  extent of 
N-glycosylation was provided by examining the inhibitory 
effect of tunicamycin. Tunicamycin inhibits the first step of 
N-glycan assembly and hence blocks N-glycosylation com- 
pletely. Metabolic labeling of hepatocytes with [3~S]methio- 
nine in the presence of tunicamycin  and subsequent immuno- 
precipitation of detergent-extracted proteins with anti-AGpll  0 
yielded a band in SDS-gels at a molecular weight position 
of 107 kD (Fig. 9 k), consistent with the results obtained af- 
ter Endo F (Fig. 9 b), and N-glycanase (Fig. 9 g) hydrolysis. 
Experiments in which cultures were pulsed for varying times 
(1-4 h) with isotope indicated the presence of a precursor of 
'~91 kD (Fig. 9, j-l) that is processed to yield the mature 
protein, as indicated after equilibrium labeling (Fig. 9. i). 
Stamatoglou  et al. Novel Fibronectin-binding Glycoprotein  2123 Figure 8. Effect of AGp110 antibody on hepatocyte spreading on type IV collagen- or laminin-coated substrata. Bar, 50 ~tm. (a) Hepatocytes 
inoculated on type IV collagen and incubated for 3 h. (b) Cells incubated for 3 h on type IV collagen and then treated with medium contain- 
ing 500 izg/ml Fab' fragments of anti-AGpll0 antibodies for l  h. (c) Hepatocytes spread on laminin after 3 h incubation. (d) Hepatocytes 
spread on laminin and then treated with anti-AGpll0 Fab'. 
Figure 9.  Glycosylation and pro- 
cessing of mpuo. Autoradiogtms 
of 7.5 % SDS gels of immttnopre- 
cipitates  of  detergent-extracted 
surface-radioiodinated  hepato- 
cytes  (a-g)  and  fluorograms  of 
SDS gels of immunoprecipitates 
of detergent-extracted  hepatocytes 
labeled metabolically with [35S]- 
methionine (h-m).  (a) Immuno- 
precipitation of detergent extracts 
of surface iodinated hepatocytes 
by  specific  AGpllO  antibodies. 
(b) Endo F treatment of iodinated 
immunopreeipitated AGp110. (c) 
Neuraminidase treatment of iodi- 
hated  AGpI10.  (d)  AGp110  im- 
munopreeipitated  from  surface- 
iodinated  hepatocytes  (same  as 
a).  (e)  Neuraminidase-treated 
AGp110  (same as  c).  (f)  Neur- 
aminidase foaowed by O-#yeanase 
treatment of AGp110. (g) N-gly- 
canase treatment of AGp-II0. (h) 
AGp110 immunoprecipitated from extracts of cells that were metabolically labeled with [35S]methionine in the presence of tunicamycin. 
(i-l) Immunoprecipitation of AGp110 from hepatocytes labeled with [3SS]methionine for 16 (i), 4 (j), 2 (k) and 1 h (l). A 91-kD precur- 
sor detected in short pulses is indicated. 
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tion of  AGp110 (a) and integrin 
(b) from surface  radioiodinated 
cells extracted under nondis- 
sociating conditions. The gels 
(7.5 %) were run in the absence 
of reducing  agents. The arrows 
in b indicate the. and/~ sub- 
units of fibronectin  receptor in- 
tegrin. Arrowheads indicate 
other proteins immunoprecip- 
itated with the anti-/3 serum 
that could possibly be differ- 
ent integrin ¢x subunits. 
Figure 10. Comparison of AGpll0 with other liver proteins. Au- 
toradiograms of  reduced 7.5 % SDS gels showing  immunoprecipita- 
tions of  surface-radioiodinated  hepatocytes  extracted with CHAPS- 
containing buffer under nondissociating conditions. (a-d) Serial 
immunoprecipitations  with AGp110 specific antiserum resulting in 
immunodepletion of AGpll0 (b-d). (e)  Immunoprecipitation of 
integrin from AGpll0-immunodepleted cell extract. (f) Immuno- 
precipitation of DPPIV from AGpll0-depleted cell extract. 
Comparison of  AGpllO with Other Parenchymal  Cell 
Surface Glycoproteins 
We compared AGpll0  with the liver fibronectin receptor 
integrin  (32)  and DPPIV,  an  enzyme that is  involved in 
fibronectin-mediated attachment of hepatocytes on collagen 
(21). Hepatocytes spread on fibronectin substrata were sur- 
face labeled by lactoperoxidase-catalyzed iodination and ex- 
tracted under nondissociating conditions (see Materials and 
Methods). Aliquots of this extract were successively immu- 
noprecipitated with anti-AGpll0 serum (Fig.  10, a-d). The 
extracts thus immunodepleted of AGpll0 were immunopre- 
cipitated with antisera against integrin (Fig. 10 e) or DPPIV 
(Fig. 10f). The results show that these proteins were present 
in the extract after AGpll0 was removed, thereby indicating 
that AGpll0 is a distinct glycoprotein. 
In immunoprecipitations of AGpll0 and integrin under 
nonreducing and nondissociating conditions (Fig.  11), we 
did not detect any change in the electrophoretic mobility of 
AGp110 in the absence of reducing agents (Fig.  11 a). The 
fact that a single band was observed in AGpll0 immunopre- 
cipitations under nondissociaring conditions either in the 
presence  (Fig.  10  a)  or absence  (Fig.  11  a)  of reducing 
agents, suggests that the protein is a monomer. In contrast, 
the dimeric structure of  the fibronectin receptor integrin was 
clearly revealed in nonreducing gels: the c~ and fi subunits 
(Fig. 11 b, arrows) ran at indicated molecular masses of 155 
and 118 kD respectively, in agreement with previous obser- 
vations (32).  The bands of higher molecular weight (Fig. 11 
b, arrowheads) that were precipitated with the anti-fi integrin 
antiserum could be different o~ subunits associated with the 
same/3~  subunit of the fibronectin receptor. 
Tissue Distribution of  AGpllO 
The distribution of AGpll0 in different tissues was deter- 
mined by Western blotting of  detergent extracts of  tissues ob- 
tained from an adult rat. Equal amounts of  protein from vari- 
ous tissues  extracted with octyl glucoside (see  Materials 
and Methods) were separated by SDS-PAGE,  blotted onto 
nitrocellulose, and probed with anti-AGpll0 (Fig.  12). The 
protein was  found mainly in liver, pancreas,  kidney, and 
small intestine. In the small intestine the protein migrated at 
a lower molecular mass (,~90 kD), possibly due to proteo- 
lyric cleavage from digestive enzymes found in that organ. 
Lesser amounts of AGpll0 were observed in lung, thymus, 
and spleen,  but it was absent in stomach, large intestine, 
heart, and thigh muscle (Fig.  12).  The results demonstrate 
that expression of AGp110 is tissue specific. 
Eh'scussion 
We have identified and partially characterized a hepatic bile 
canalicular protein, AGpll0, that interacts with fibronectin. 
Figure 12. Relative  amounts  of AGp110 in various rat tissues. Equal 
amounts of  protein (100/~g) from tissues extracted with octyl gluco- 
side were subjected to SDS-PAGE. The separated proteins were 
transferred to  nitrocellulose and probed with anti-AGpll0 and 
peroxidase-conjugated anti-rabbit IgG. 
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tracellular  domain  that  is  extensively  glycosylated with 
sialylated O-glycans and one or two N-glycan chains. The 
functional significance of the binding to  fibronectin was 
demonstrated in adhesion assays in which spreading of  hepa- 
tocytes was arrested and reversed by antibodies to AGpll0. 
In that respect therefore, the protein functions as a fibronec- 
tin receptor.  The fibronectin receptor integrin of rat liver 
(32) and AGpll0 seem to be distinct proteins: they migrate 
to different molecular weight positions in  SDS  gels,  im- 
munodepletion of AGpI10 does not remove integrin from 
cell extracts and anti-AGpll0 does not recognize the paren- 
chymal integrin. Furthermore, the fact that our experiments 
indicate that the protein is a monomer without extensive in- 
trachain disulfide bonding argues against it being a heterodi- 
mer or a fl-subunit from the integrin groups discovered so 
far (14, 29, 34). 
Integrins are the major cell surface receptors for extracel- 
lular  matrix  components  including  fibronectin,  but  pro- 
teoglycans (50), gangliosides (11, 35), and other glycopro- 
teins (2, 57) have also been shown to exhibit receptor-like 
activities  in  cell-fibronectin  interactions.  As  regards  the 
integrin  family of macromolecules,  fibronectin  receptor 
integrins  from  liver  parenchyma  and  endothelium  have 
different a  subunits but share a common fl subunit (32, 33). 
T lymphocytes have two integrin receptors (58), which are 
dimers of the a~l and c~5fll type. In agreement with this, 
our experiments suggest that the fl subunit (fl~ type) of he- 
patocyte integrin (32) may associate with different  a subunits 
to  form multiple heterodimers.  This plurality of cellular 
receptors corroborates findings on multiple ligand sites on 
the fibronectin molecule: the main cell adhesion fibronectin 
fragment contains the RGD cell recognition signal, while the 
heparin-binding domains activate adhesion by linkage to cell 
surface heparan sulfate (1,  29,  49,  51). The alternatively- 
spliced type III connecting segment (IIICS) that lies between 
the  COOH-terminal  heparin and fibrin domains has  two 
adhesion-promoting sequences (26, 28): one of these (CS5) 
contains the peptide REDV (i  n human fibronectin- in the rat 
it mutates to RGDV [52]), which supports melanoma but not 
fibroblast cell attachment (26, 28), while the other (denoted 
CS1) induces neurite extension (27) and contains a peptide 
sequence recognized by the c~4fl~ integrin of peripheral blood 
and cultured T lymphocytes (58).  The latter integrin has no 
affinity for RGD. In addition to these adhesion domains, evi- 
dence exists for yet another sequence operating in synergy 
with RGD (16). In this context, the discovery of a dual fibro- 
nectin  receptor  system in  liver  parenchyma,  comprising 
AGpll0 as well as integrin(s), although novel, follows the 
concept of fibronectin receptor plurality as discussed above. 
Our adhesion experiments show that initial attachment of 
hepatocytes on fibronectin are not blocked with anti-AGp110, 
whereas spreading of ceils in 3-h-old cultures can be re- 
versed. This indicates a minor (if any) role of AGp110 in ini- 
tiai contact to fibronectin, but a significant contribution in 
initiating or maintaining cell spreading. Since inhibition of 
integrin function with specific antisera also reverses spread- 
ing (30),  active spreading may require co-operative action 
from both receptors, whereas integrin alone may suffice to 
effect initial attachment. 
Among nonintegrin hepatic glycoproteins with molecular 
weight similar to AGpll0, DPPIV is involved in fibronectin- 
mediated adhesion of hepatocytes on collagen (21). Appar- 
ently, DPPIV is found on the bile canalicular surface (22), 
although other data suggests a less polarized distribution (9). 
Our immunodepletion experiments (Fig. 10) and other sero- 
logical comparisons using our anti-AGp110 serum and mono- 
clonal antibodies against DPPIV indicate that DPPIV and 
AGp110 are distinct proteins. Cell-CAM 105, an intercellular 
adhesion molecule (41, 43) shows a low level of antigenic 
cross-reactivity with AGpll0, but behaves differently under 
nonreducing conditions in SDS-PAGE and is N-glycosylated 
to a significantly  higher degree that AGp110 (43), so identity 
is unlikely. A transformation-sensitive ll0-kD glycoprotein 
has also been localized in bile canalicular plasma membranes, 
but has a slightly more acidic isoelectric point and displays 
a different tissue distribution (4). AGpll0 may, however, be 
related to a monocyte fibronectin receptor described previ- 
ously (23):  this protein  (Mr  105  kD)  is also a  monomer 
with no indication of intrachain disulfide bonds. 
The physiological role of a double-receptor system in the 
liver parenchyma is not clear.  Multiple receptors for fibro- 
nectin could confer tissue specificity in adhesive interactions 
or modulate phenomena such as cell migration and selective 
adhesion in either normal programmed events, such as devel- 
opment, or in pathological conditions, such as the neoplastic 
state in which the spectrum of integrins is known to be al- 
tered (45).  Fibronectin in rat liver shows  an uneven, but 
essentially nonpolarized distribution with respect to the hep- 
atocellular surface: the protein can be found on the canalicu- 
lar and lateral surfaces (25)  but is most prominent in the 
perisinusoidal space (25, 39). Recently, different fibronectin 
isoforms have been found on each hepatocellular surface do- 
main (18), thus necessitating a sorting mechanism perhaps 
provided by different receptors.  Such  a  putative role  for 
AGp110 would not exclude a functional, perhaps transient, 
involvement in adhesive interactions in vivo under condi- 
tions where the strict polarization of the hepatocellular sur- 
face is perturbed such as during cell division in expansion 
of the liver parenchyma. Antigens found on the bile canalicu- 
lar surface in adult liver have been shown to exhibit a differ- 
ent distribution in the embryonic liver (40),  in hepatocar- 
cinogenesis (53) and during liver regeneration after partial 
hepatectomy (42). 
In conclusion, we have demonstrated the existence of a 
novel glycoprotein in liver parenchyma that is active in medi- 
ating spreading of cultured hepatocytes on fibronectin sub- 
strata. AGpll0 and integrin fibronectin receptor are distinct 
proteins  suggesting that a  dual receptor  system mediates 
cell-fibronectin interactions in the liver parenchyma. 
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